InsidersTradesSigma
Track the CEMPRA, INC. share price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was disclosed on 6 January 2016 (Levée d'options). Among the most active insiders: GOLDSTEIN DOV A MD. Every trade is accessible without an account.
Analysts rate CEMPRA, INC. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Cempra, Inc. is a biopharmaceutical company focused on developing treatments for bacterial infections. It is listed on NASDAQ under the symbol CEMP.